Amit Joharapurkar

1.7k total citations
71 papers, 1.3k citations indexed

About

Amit Joharapurkar is a scholar working on Endocrinology, Diabetes and Metabolism, Molecular Biology and Surgery. According to data from OpenAlex, Amit Joharapurkar has authored 71 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 30 papers in Endocrinology, Diabetes and Metabolism, 23 papers in Molecular Biology and 16 papers in Surgery. Recurrent topics in Amit Joharapurkar's work include Diabetes Treatment and Management (19 papers), Pancreatic function and diabetes (11 papers) and Metabolism, Diabetes, and Cancer (8 papers). Amit Joharapurkar is often cited by papers focused on Diabetes Treatment and Management (19 papers), Pancreatic function and diabetes (11 papers) and Metabolism, Diabetes, and Cancer (8 papers). Amit Joharapurkar collaborates with scholars based in India, United States and Poland. Amit Joharapurkar's co-authors include Mukul R. Jain, Vishal Patel, Samadhan Kshirsagar, Nirav Dhanesha, Rajesh Bahekar, Gaurang Shah, Vrajesh B. Pandya, Ranjit C. Desai, Dipam Patel and Sudhir N. Umathe and has published in prestigious journals such as SHILAP Revista de lepidopterología, Diabetes and Journal of Medicinal Chemistry.

In The Last Decade

Amit Joharapurkar

68 papers receiving 1.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Amit Joharapurkar India 23 489 416 242 163 149 71 1.3k
Jingping Ouyang China 22 733 1.5× 198 0.5× 161 0.7× 150 0.9× 116 0.8× 56 1.7k
Evelyne Véricel France 27 548 1.1× 158 0.4× 297 1.2× 260 1.6× 216 1.4× 75 2.0k
Shudong Wang China 23 1.0k 2.1× 221 0.5× 244 1.0× 181 1.1× 111 0.7× 40 1.9k
Haruhisa Otani Japan 18 460 0.9× 155 0.4× 453 1.9× 158 1.0× 120 0.8× 46 1.5k
Uday Saxena United States 26 649 1.3× 698 1.7× 542 2.2× 214 1.3× 96 0.6× 54 2.1k
Jie Liao United States 23 635 1.3× 126 0.3× 133 0.5× 101 0.6× 137 0.9× 37 1.6k
Xiao Miao China 22 800 1.6× 164 0.4× 112 0.5× 169 1.0× 76 0.5× 29 1.6k
Reeba K. Vikramadithyan United States 18 654 1.3× 218 0.5× 146 0.6× 237 1.5× 95 0.6× 27 1.2k
Gehan H. Heeba Egypt 25 458 0.9× 233 0.6× 200 0.8× 166 1.0× 165 1.1× 50 1.5k
Susan Butler United States 9 653 1.3× 246 0.6× 704 2.9× 283 1.7× 96 0.6× 16 2.7k

Countries citing papers authored by Amit Joharapurkar

Since Specialization
Citations

This map shows the geographic impact of Amit Joharapurkar's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Amit Joharapurkar with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Amit Joharapurkar more than expected).

Fields of papers citing papers by Amit Joharapurkar

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Amit Joharapurkar. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Amit Joharapurkar. The network helps show where Amit Joharapurkar may publish in the future.

Co-authorship network of co-authors of Amit Joharapurkar

This figure shows the co-authorship network connecting the top 25 collaborators of Amit Joharapurkar. A scholar is included among the top collaborators of Amit Joharapurkar based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Amit Joharapurkar. Amit Joharapurkar is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Joharapurkar, Amit, et al.. (2025). Pharmacological effect of ZYGK1, a novel glucokinase activator, in hyperglycemic and sulfonylurea-resistant type 2 diabetes in mice models. Journal of Diabetes and its Complications. 39(3). 108977–108977. 1 indexed citations
2.
Joharapurkar, Amit, et al.. (2024). Prolyl hydroxylase inhibitor desidustat attenuates autoimmune hemolytic anemia in mice. International Immunopharmacology. 142(Pt A). 113029–113029. 1 indexed citations
3.
Joharapurkar, Amit, Vrajesh B. Pandya, Harilal Patel, Mukul Jain, & Ranjit C. Desai. (2024). Desidustat: a novel PHD inhibitor for the treatment of CKD-induced anemia. SHILAP Revista de lepidopterología. 4. 1459425–1459425. 3 indexed citations
4.
Joharapurkar, Amit, et al.. (2024). HIF-PHD inhibitor desidustat ameliorates iron deficiency anemia. Toxicology and Applied Pharmacology. 483. 116832–116832. 5 indexed citations
5.
Joharapurkar, Amit, et al.. (2024). The Perspective of Using Flow Cytometry for Unpuzzling Hypoxia-Inducible Factors Signalling. Drug Research. 74(3). 113–122. 1 indexed citations
6.
Patel, Vishal, et al.. (2020). Combination of Lorcaserin and GLP-1/glucagon Coagonist Improves Metabolic Dysfunction in Diet Induced-obese Mice. Drug Research. 70(8). 376–384. 1 indexed citations
7.
Patel, Vishal, Amit Joharapurkar, Samadhan Kshirsagar, et al.. (2015). Central GLP-1 receptor activation improves cholesterol metabolism partially independent of its effect on food intake. Canadian Journal of Physiology and Pharmacology. 94(2). 161–167. 13 indexed citations
8.
Patel, Jayendra Z., Tapio Nevalainen, Juha R. Savinainen, et al.. (2014). Optimization of 1,2,5‐Thiadiazole Carbamates as Potent and Selective ABHD6 Inhibitors. ChemMedChem. 10(2). 253–265. 28 indexed citations
9.
Bahekar, Rajesh, Shailesh R. Shah, Dipam Patel, et al.. (2014). Design, synthesis and biological evaluation of novel aminomethyl-piperidones based DPP-IV inhibitors. Bioorganic & Medicinal Chemistry Letters. 24(8). 1918–1922. 17 indexed citations
10.
Patel, Vishal, Amit Joharapurkar, Nirav Dhanesha, et al.. (2013). Combination of omeprazole with GLP-1 agonist therapy improves insulin sensitivity and antioxidant activity in liver in type 1 diabetic mice. Pharmacological Reports. 65(4). 927–936. 28 indexed citations
11.
Bahekar, Rajesh, Shailesh R. Shah, Dipam Patel, et al.. (2012). Design of Peptidomimetic Based DPP-IV Inhibitors, Devoid of CYP Liabilities. Letters in Drug Design & Discovery. 9(9). 867–873.
12.
Joharapurkar, Amit, et al.. (2012). 11β-Hydroxysteroid dehydrogenase type 1: potential therapeutic target for metabolic syndrome. Pharmacological Reports. 64(5). 1055–1065. 27 indexed citations
13.
Bahekar, Rajesh, Shailesh R. Shah, Dipam Patel, et al.. (2012). Long-acting peptidomimetics based DPP-IV inhibitors. Bioorganic & Medicinal Chemistry Letters. 22(10). 3516–3521. 24 indexed citations
14.
Srivastava, Brijesh Kumar, Rina Soni, Jayendra Z. Patel, et al.. (2009). Hair growth stimulator property of thienyl substituted pyrazole carboxamide derivatives as a cb1 receptor antagonist with in vivo antiobesity effect. Bioorganic & Medicinal Chemistry Letters. 19(9). 2546–2550. 21 indexed citations
15.
Bandyopadhyay, Debdutta, Hiren R. Modi, Amit Joharapurkar, et al.. (2008). Design and synthesis of novel 3-hydroxy-cyclobut-3-ene-1,2-dione derivatives as thyroid hormone receptor β (TR-β) selective ligands. Bioorganic & Medicinal Chemistry Letters. 18(14). 3919–3924. 7 indexed citations
16.
Srivastava, Brijesh Kumar, Rina Soni, Amit Joharapurkar, et al.. (2007). Bioisosteric replacement of dihydropyrazole of 4S-(−)-3-(4-chlorophenyl)-N-methyl-N′-[(4-chlorophenyl)-sulfonyl]-4-phenyl-4,5-dihydro-1H-pyrazole-1-caboxamidine (SLV-319) a potent CB1 receptor antagonist by imidazole and oxazole. Bioorganic & Medicinal Chemistry Letters. 18(3). 963–968. 11 indexed citations
17.
Srivastava, B. K., Mukul R. Jain, Amit Joharapurkar, et al.. (2006). SAR and antiobesity effect of Diaryl dihydropyrazole-3-carboxamides class of CB1 receptor antagonists. Medicinal Chemistry Research. 1 indexed citations
18.
Joharapurkar, Amit, et al.. (2005). Antinociceptive activity of alcoholic extract of Hemidesmus indicus R.Br. in mice. Journal of Ethnopharmacology. 102(2). 298–301. 87 indexed citations
19.
Joharapurkar, Amit, et al.. (2004). Pyrogallol: A novel tool for screening immunomodulators. Indian Journal of Pharmacology. 36(6). 355–359. 25 indexed citations
20.
Joharapurkar, Amit, et al.. (2003). In vivo evaluation of antioxidant activity of alcoholic extract of Rubia Cordifolia Linn. and its influence on ethanol-induced immunosuppression. Indian Journal of Pharmacology. 35(4). 232–236. 54 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Jingping Ouyang Breakdown of academic impact, for papers by Evelyne Véricel Breakdown of academic impact, for papers by Shudong Wang Breakdown of academic impact, for papers by Haruhisa Otani Breakdown of academic impact, for papers by Uday Saxena Breakdown of academic impact, for papers by Jie Liao Breakdown of academic impact, for papers by Xiao Miao Breakdown of academic impact, for papers by Reeba K. Vikramadithyan Breakdown of academic impact, for papers by Gehan H. Heeba Breakdown of academic impact, for papers by Susan Butler
Rankless by CCL
2026